Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Differences in Inflammation, Cardiovascular Risk Factors and Respiratory Health with Use of Menthol Cigarettes: Informing the Regulation of Tobacco Flavorings to Protect Public Health

Award Number: R03HL147318
ORGANIZATION: NATIONAL HEART, LUNG, & BLOOD INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 06/01/2019
PERIOD OF PERFORMANCE END DATE: 05/31/2021

Group Awards By:

View Award Description

Differences in Inflammation, Cardiovascular Risk Factors and Respiratory Health with Use of Menthol Cigarettes: Informing the Regulation of Tobacco Flavorings to Protect Public Health - Project Title: “Differences in Inflammation, Cardiovascular Risk Factors and Respiratory Health with Use of Menthol Cigarettes: Informing the Regulation of Tobacco Flavorings to Protect Public Health” Abstract/Project Summary Despite smoking fewer cigarettes per day, Black men and women are at greater risk for some tobacco-related diseases including cardiovascular and respiratory diseases, compared to their white counterparts. The substantially higher prevalence of menthol cigarette use among Black smokers may contribute to these disparities. The Family Smoking Prevention and Tobacco Control Act gave the Food and Drug Administration Center for Tobacco Products (CTP) the authority to restrict the manufacture, sale and distribution of menthol cigarettes as appropriate to protect public health. An important part of the determination for the regulation of menthol cigarettes concerns the health effects of mentholated relative to nonmentholated cigarettes. Studies examining differences in health effects with menthol cigarette use have mainly focused on all-cause mortality and cancer outcomes, with few studies considering cardiovascular or pulmonary outcomes. There is limited information regarding potential differences in cardiovascular risk factors or respiratory health with menthol cigarette use and no studies have examined differences in inflammation comparing menthol and nonmenthol cigarette smokers. Therefore, the main objective of this project is to evaluate differences in systemic inflammation, cardiovascular risk factors and respiratory health with use of menthol cigarettes among smokers in the US. To meet this objective, we will leverage existing, publicly accessible interview, physical examination and biological specimen data from 9,880 adult current smokers who participated in the National Health and Nutrition Examination Survey (NHANES), a series of nationally-representative surveys of the US population, from 1999 through 2016. Multivariable adjusted linear and logistic regression models will be used to evaluate the associations between menthol compared to nonmenthol cigarette use with: (1) markers of systemic inflammation (C-reactive protein, fibrinogen, white blood cell count, and homocysteine); (2) cardiovascular risk factors (hypertension, diabetes, and reduced kidney function); and (3) respiratory health outcomes (fractional exhaled nitric oxide levels, spirometry-defined pulmonary impairment, past year wheeze, and frequent cough and frequent phlegm). This proposed research will provide needed information to guide the CTP determination regarding the banning of menthol cigarettes. Findings from this study will provide insight into differences in risk of tobacco-related diseases that could have implications for the regulation of menthol cigarettes in the US, including the potential health impacts to Black communities who are burdened by greater menthol cigarette advertising and promotion.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2023 ( Subtotal = -$2,204 )
2023	2020	THE JOHNS HOPKINS UNIVERSITY	3400 N CHARLES ST	BALTIMORE	MD	21218	BALTIMORE CITY	USA	Family Smoking Prevention and Tobacco Control Act Regulatory Research	000	2	3/15/2023	NON-COMPETING CONTINUATION	-$2,204
														Subtotal = -$2,204

Issue Date FY: 2022 ( Subtotal = -$23,852 )
2022	2020	JOHNS HOPKINS UNIVERSITY, THE	3400 N CHARLES ST	BALTIMORE	MD	21218	BALTIMORE CITY	USA	Family Smoking Prevention and Tobacco Control Act Regulatory Research	000	2	11/7/2021	NON-COMPETING CONTINUATION	-$23,852
														Subtotal = -$23,852

Issue Date FY: 2020 ( Subtotal = $81,875 )
2020	2020	JOHNS HOPKINS UNIVERSITY, THE	3400 N CHARLES ST	BALTIMORE	MD	21218	BALTIMORE CITY	USA	Family Smoking Prevention and Tobacco Control Act Regulatory Research	000	2	6/10/2020	NON-COMPETING CONTINUATION	$81,875
														Subtotal = $81,875

Issue Date FY: 2019 ( Subtotal = $81,875 )
2019	2019	JOHNS HOPKINS UNIVERSITY, THE	3400 N CHARLES ST	BALTIMORE	MD	21218	BALTIMORE CITY	USA	Family Smoking Prevention and Tobacco Control Act Regulatory Research	000	1	5/21/2019	NEW	$81,875
														Subtotal = $81,875

Grand Total All Awards = $137,694

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Differences in Inflammation, Cardiovascular Risk Factors and Respiratory Health with Use of Menthol Cigarettes: Informing the Regulation of Tobacco Flavorings to Protect Public Health

Award Number: R03HL147318

ORGANIZATION: NATIONAL HEART, LUNG, & BLOOD INSTITUTE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 06/01/2019

PERIOD OF PERFORMANCE END DATE: 05/31/2021

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer